Navigation Links
Kantar Health Uncovers Opportunities and Challenges for Biosimilars in Asia
Date:11/11/2013

New York, NY (PRWEB) November 12, 2013

Kantar Health, a leading global healthcare consulting firm, will release new details on biosimilar opportunities and challenges for pharmaceutical manufacturers in Asia at the EphMRA 2013 Asia Conference on November 14 in Singapore. Questa Lin, General Manager, Taiwan, and Simon Li, General Manager, China, will present.

In their presentation, “Uncover Biosimilars Opportunities and Challenges – Utilising Market Insights,” Ms. Lin and Mr. Li will provide a comprehensive understanding of the opportunities and barriers for developing biosimilars, how to apply market access strategies, and the research required to produce forecasting estimates.

In addition, Alice Lee, Regional Talent Director at Kantar Health, will participate in the panel discussion “Talent Management Issues” on November 13, which will focus on challenges in recruiting and retaining market researchers.

Kantar Health is a Silver Sponsor of the EphMRA 2013 Asia Conference. More information on this event can be found at http://www.ephmra.org/events/2013-asia-conference.aspx.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11319731.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Patients Experience Impairments Just One Year After Knee Replacement Surgery, According to New Kantar Health Research
2. Kantar Health to Highlight Strategies for Accessing U.S. and EU Markets for Japan Pharma
3. Kantar Health to Highlight Role of Patient-Reported Outcomes in Russia
4. New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
5. Biologic Treatment of Rheumatoid Arthritis Is Low in Brazil, According to Kantar Health Research
6. Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research
7. Kantar Health Americas CEO Mike Kelly Named to PharmaVOICE 100 for 2013
8. Kantar Health Launches CancerMPact Biomarker Analysis
9. Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
10. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
11. Kantar Health to Present at PBIRG Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... D.C. (PRWEB) , ... March 23, 2017 , ... ... (LEAD Coalition) stands with all Americans facing life-altering and fatal diseases in opposition ... budget makes shortsighted decisions that would eviscerate care, services, and hope for the ...
(Date:3/23/2017)... ... , ... The Boulevard is honored to host Shriners and Masons Children’s Day ... in the Main West Entrance of The Boulevard (in front of JCPenney). , ... and each child with a parent or guardian will be photographed for free and ...
(Date:3/23/2017)... ... 23, 2017 , ... “Wounded Woman Be Ye Healed-Passing On A Legacy”: a ... Legacy” is the creation of published author, Desiree M Webb, a registered nurse, minister ... has been happily married to her husband, Paul, for over twenty-nine years. Desiree ...
(Date:3/23/2017)... ... March 23, 2017 , ... “The Trainer”: an electrifying ... author, Scotty, a fiction writer with an active imagination and an enthusiasm for action ... follows the tale of Wild Bill Hart, who sat looking at the thirty-three notches ...
(Date:3/22/2017)... ... March 22, 2017 , ... Cosmetic Town, ... first issue of its companion print magazine. The new magazine, scheduled for release ... to information provided by board-certified doctors from across the country. , According to ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
(Date:3/23/2017)... 23, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or ... pharmaceutical company, is pleased to announce that its ... from the U.S. Food and Drug Administration (FDA) ... for tetrabenazine tablets in the 12.5 mg and ... a generic equivalent of the branded product Xenazine ...
(Date:3/23/2017)... , March 23, 2017   Casetabs , the ... native mobile app for the iPhone. With this new ... coordination and communication for physician offices, ambulatory surgery centers ... app offers iPhone users even faster, more reliable access ... it even easier to connect care teams so that ...
Breaking Medicine Technology: